Global Head Lice Infestation Drug Market Strategic Research Report

Scope of the Report

The global Head Lice Infestation Drug market size is predicted to grow from US$ 445 million in 2025 to US$ 554 million in 2032; it is expected to grow at a CAGR of 3.2% from 2026 to 2032.

Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.

Global Head Lice Infestation Drug key players include Perrigo, Bayer, Prestige Brands, Stada Arzneimittel, Alliance Pharma, etc. Global top five manufacturers hold a share about 35%. Europe is the largest market, with a share about 40%, followed by North America, with a share about 35 percent. In terms of product, Shampoo is the largest segment, with a share about 45%. And in terms of application, the largest application is Children, followed by Adult.

This report presents a comprehensive overview of the global Head Lice Infestation Drug market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Lotion
• Creams
• Shampoo
• Other

Segment by Application

• Children
• Adult

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Head Lice Infestation Drug market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Children, Adult evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact